Clinical Trial Results:
A Randomized, Open-Label, Single-Dose, Parallel Group Study to Evaluate the Utility of Magnetic Resonance Imaging (MRI) in Demonstrating the Nasal Decongestant Efficacy of an Active Control (Vicks® Sinex® Micromist®) Relative to a Sham Control at 8 and 12 Hours Post-Dosing
Summary
|
|
EudraCT number |
2011-002443-10 |
Trial protocol |
GB |
Global completion date |
01 Dec 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
26 Jun 2022
|
First version publication date |
26 Jun 2022
|
Other versions |
|
Summary report(s) |
Justification Letter |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.